Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT01987843 · COMPLETED
Trial details
- NCT number
- NCT01987843
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-09-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.